CURE - Direxion Daily Healthcare Bull 3X Shares
| Previous Close | 52.38 |
| Open | 0.00 |
| Bid | 50.48 x 1400 |
| Ask | 55.01 x 800 |
| Day's Range | 52.19 - 52.91 |
| 52 Week Range | 38.98 - 68.58 |
| Volume | 20,344 |
| Avg. Volume | 57,521 |
| Net Assets | 131.11M |
| NAV | 52.39 |
| PE Ratio (TTM) | N/A |
| Yield | 0.61% |
| YTD Return | 10.18% |
| Beta (3Y Monthly) | 2.58 |
| Expense Ratio (net) | 1.08% |
| Inception Date | 2011-06-15 |
- Simply Wall St.
Does Biocure Technology (CNSX:CURE) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
- Benzinga
It's Time To Consider Leveraged Healthcare ETFs
With one of the industry's marquee conferences recently ending, traders may want to consider the Direxion Daily Healthcare Bull 3X Shares (NYSE: CURE) and the Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU). The American Society of Clinical Oncology Annual Meeting ended this week, which could bring CURE and LABU into focus for active traders.
- ETF Trends
Health Care ETFs Could be Cure for Trade War Blues
Whether the markets are roaring or experiencing doldrums, health care exchange-traded funds (ETFs) have been a paragon of reliability, and could be the safe haven investors need to cure the trade war blues. For traders, this could bode well for the Direxion Daily Healthcare Bull 3X ETF (CURE). In particular, the pharmaceutical business is experiencing a profit squeeze as a result of lesser-than-expected revenue from the sale of generic drugs.
- Simply Wall St.
How Much Of Biocure Technology Inc. (CNSX:CURE) Do Insiders Own?
If you want to know who really controls Biocure Technology Inc. (CNSX:CURE), then you'll have to look at the makeup of...
- ETF Trends
Health Care ETFs Get a Boost From Latest Jobs Report
Job growth in March made a comeback following a less-than-stellar February as 196,000 jobs were created as opposed to 175,000 expected by economists with a good portion coming from the health care sector, ...
- Newsfile
BiocurePharm, Korea ("BPK") Announces Closing of Private Placement
Vancouver, British Columbia--(Newsfile Corp. - February 28, 2019) - Biocure Technology Corp. (CSE:CURE) (OTCQB: BICTF) ("CURE" or the "Company") BiocurePharm, Korea ("BPK"), a wholly owned subsidiary of Biocure Technology Inc. ("CURE") is pleased to announce that it has closed its non-brokered private placement through its Korean Subsidiary BiocurePharm, Korea ("BPK"), BPK has issued 96,404 shares at $11.45 CAD per share for gross proceeds of $1,103,749. After the issuance of new BPK shares, CURE holds ...
- ETF Trends
Things Are About to Get Interesting For Healthcare Leveraged ETF
This week, traders have been focusing on fourth-quarter earnings reports from the financial services sector. A spate of healthcare earnings reports next week could spur interest in the Direxion Daily Healthcare Bull 3X ETF (CURE). CURE seeks daily investment results equal to 300% of the daily performance of the Health Care Select Sector Index.
- ETF Trends
Rising U.S. Health Care Spending a Boon to this Leveraged ETF
According to a new analysis from Johns Hopkins Bloomberg School of Public Health, Americans spend more than twice as much on health care per person versus other developed nations, which is a boon to the Direxion Daily Healthcare Bull 3X ETF (CURE). CURE seeks daily investment results equal to 300% of the daily performance of the Health Care Select Sector Index.
ZacksInverse & Leveraged ETFs: What Investors Need to Know
Market volatility is back. Here is what investors need to know about using inverse & leveraged ETFs to make money from wild swings.
- Zacks
How To Profit From Market Volatility Using Inverse & Leveraged ETFs
Market volatility is back. Here is what investors need to know about using inverse & leveraged ETFs to make money from wild swings.
- Zacks
S&P 500 Posts Best Week in 7 Years: 5 Best Leveraged ETFs
The S&P 500 and Nasdaq Composite Index logged in the best week since 2011 on optimism over the U.S.-China trade truce and a dovish Fed view.
- ETF Trends
Leveraged Healthcare ETF Gains On Midterm Election Results
Even as the Democrats retook control of the House of Representatives and the Republicans maintained majority in the Senate, healthcare ETFs were also big winners following the 2018 Midterm Election results. ...
- ETF Trends
3 Midterm Election Issues that Could Move Leveraged Healthcare ETF
As investors got washed through a cycle of volatility in October, one of the sectors that could see ample interest as growth-fueled tech continues to come out of favor is health care and with healthcare issues abound in Tuesday's midterm elections, leveraged ETF plays like the Direxion Daily Healthcare Bull 3X ETF (CURE) could move following the election results. CURE seeks daily investment results equal to 300% of the daily performance of the Health Care Select Sector Index.
- ETF Trends
An Adventurous Idea For Healthcare Earnings Season
Risk-tolerant traders looking for some added excitement with the healthcare during third-quarter earnings season have several leveraged ETFs to consider. The Direxion Daily Healthcare Bull 3X ETF (NYSEArca: ...
- ETF Trends
This Leveraged Health Care ETF is the ‘CURE’ for Late Market Cycle Blues
One sector that could see continued strength once this bull run begins to lose its momentum is health care, and leveraged ETF plays like the Direxion Daily Healthcare Bull 3X ETF (CURE) could be worth a look. CURE seeks daily investment results equal to 300% of the daily performance of the Health Care Select Sector Index. According to an article in Reuters, health care has been in the forefront in the major sectors of the S&P 500 for the third quarter, rising as much as 13%.
- Zacks
Best Leveraged ETFs of Q3
Inside the top-performing leveraged ETFs of the third quarter of 2018.
